To prevent chlamydia, use condoms correctly every time you have vaginal, anal, or oral sex, get screened on schedule if you're sexually active, and make sure any partner who tests positive is treated before you have sex again. Most infections cause no symptoms, so routine testing and partner treatment do more to stop the chain than condoms alone.
urine or swab
after exposure
100 mg 2×/day, 7 days
catches reinfection
| Item | Value |
|---|---|
| Test method | NAAT — urine or swab |
| When to test | ~2 wks — after exposure |
| Treatment | doxycycline — 100 mg 2×/day, 7 days |
| Retest | 3 mo — catches reinfection |
How do you actually prevent chlamydia?
Chlamydia is caused by the bacterium Chlamydia trachomatis, and most genital infections in the US come from serovars D through K CDC, About Chlamydia. It spreads through vaginal, anal, or oral sex, and a pregnant woman can pass it to her baby during childbirth. The bacterium is fragile outside the body, so prevention comes down to what happens during sexual contact and to catching silent infections before they're passed on.
It's the most commonly reported bacterial STI in the country, with about 1.65 million reported cases in 2023, roughly 492 per 100,000 people, a rate that has stayed about flat from 2020 through 2023 CDC AtlasPlus, 2023. That sheer volume means no single tool is enough on its own. The methods that work, ranked by how much they reduce risk:
- Use condoms correctly and consistently. Latex or polyurethane condoms used every time, start to finish, are a proven barrier against the fluids and contact that transmit chlamydia.
- Get screened on the recommended schedule. Since most infections are silent, testing finds and stops infections you'd never notice. For the people most at risk, this is the highest-yield step you can take.
- Treat partners before resuming sex. An untreated partner re-infects you within weeks; partner treatment breaks that loop.
- Consider DoxyPEP if you're eligible. A single dose of doxycycline taken soon after sex measurably lowers risk for specific groups.
- Limit concurrent partners or stay in a long-term, mutually monogamous relationship with a partner who has tested negative.
How well do condoms work — and where do they fall short?
Condoms used correctly every single time are one of the cornerstones of prevention. They physically block the genital secretions that carry the bacterium, and because chlamydia lives in those fluids and on mucosal surfaces, a barrier that covers the contact area substantially cuts transmission.
The limits are practical, not theoretical. Condoms only protect the skin they cover, so contact before the condom goes on, oral sex done without one, or inconsistent use all leave gaps. People skip the "correctly every time" part, and a single unprotected encounter with an infected partner is enough. Condoms reduce risk rather than erase it, so pairing them with testing matters. If you're weighing how chlamydia compares to its frequent co-traveler, see chlamydia vs gonorrhea.
Why testing is the real prevention tool
Most chlamydia infections produce no symptoms at all, so people transmit it without ever knowing they're infected. Screening tests someone who feels fine, and that interrupts transmission. Find it, treat it, and it can't be passed on. Chlamydia is curable with the right antibiotics CDC Chlamydia Fact Sheet.
Screening guidance is deliberately asymmetric. The USPSTF gives a Grade B recommendation, meaning screen, for all sexually active women age 24 and under, and for older women at increased risk, but issues an I-statement (insufficient evidence) for screening men USPSTF. The serious complications, pelvic inflammatory disease and infertility, fall on women, so the evidence for benefit is strongest there.
The recommended test is a NAAT (nucleic acid amplification test), the most sensitive method for both genital and extragenital infection. It works on several specimen types depending on the exposure: first-catch urine, vaginal or endocervical swabs, male urethral swabs, and rectal or pharyngeal swabs for anal and oral sites. A urine sample or self-collected swab is enough for most people, with no exam required. For the full walk-through of what a visit involves, see chlamydia testing & diagnosis, and if you've had a recent exposure, check when to test after exposure so you don't test too early to catch it. Ready to book? You can get tested without an office visit in many areas.
A positive result is routine and curable, not a verdict on your character. Clinics manage these cases every day, and in many states you can notify partners anonymously.
Treating partners closes the loop
Treating your partners is prevention for you. If a partner stays infected, they re-infect you the next time you have sex, and the cycle repeats. The benefit is measurable: in a landmark randomized trial of expedited partner therapy (giving the patient medication to deliver to their partner), persistent or repeat infection dropped, with the largest benefit seen for gonorrhea, about 3% versus 11% Golden et al., NEJM.
Practically, this means abstaining from sex until both you and your partners have completed treatment, and getting re-tested down the line because repeat infection is common. The details of catching those second-round cases live in chlamydia reinfection.
Is there a vaccine, PrEP, or DoxyPEP for chlamydia?
There's no chlamydia vaccine, and HIV PrEP doesn't prevent it. DoxyPEP does. A single 200 mg dose of doxycycline taken within 72 hours of sex reduces chlamydia by more than 70% CDC DoxyPEP. Under the 2024 CDC guidance, it's offered to gay and bisexual men and transgender women who've had a bacterial STI in the past 12 months CDC DoxyPEP Guidelines, 2024.
DoxyPEP is not for everyone, and it doesn't replace condoms or screening. It's an add-on for higher-risk people, prescribed and monitored by a clinician. If you think you might be eligible, raise it specifically at your next visit.
Putting it together: a realistic prevention plan
No single layer is airtight, so stack them according to your own risk. Here's how the main tools compare in plain terms:
| Method | How well it works | Best for |
|---|---|---|
| Condoms, every time | Strong barrier, but only covers contact it covers | Everyone having sex with new or untested partners |
| Routine screening | Catches silent infection so it can't spread | Sexually active women 24 and under; anyone with new partners |
| Partner treatment | Cuts persistent and repeat infection | Anyone who tests positive and their recent partners |
| DoxyPEP (single dose <72h) | Reduces chlamydia by >70% | MSM and transgender women with a recent bacterial STI |
| Mutual monogamy with a tested partner | Very effective once both test negative | Established, exclusive relationships |
For most people the high-yield combination is simple: condoms with new partners, a test on the recommended schedule, and prompt treatment for anyone who's positive, partners included. Add DoxyPEP only if you fit the criteria. Risk isn't evenly spread. Rates are highest in Washington DC (1,228 per 100,000), Louisiana (792), and Mississippi (701), more than double the national rate, so local prevalence shapes how aggressively you should screen CDC STI Surveillance.
When to see a clinician
See a clinician if you've had a new or untested partner, if a partner tells you they tested positive, or if you notice unusual discharge, burning with urination, pelvic pain, or rectal symptoms. Pregnant people should be tested as part of prenatal care, since untreated infection can pass to the baby during delivery. Watch for one uncommon but serious presentation: lymphogranuloma venereum (LGV), caused by invasive serovars L1–L3, which most often shows up in men who have sex with men as proctocolitis, with mucoid or bloody rectal discharge, anal pain, and tenesmus (a constant urge to pass stool). LGV needs a longer antibiotic course than ordinary chlamydia, so don't self-diagnose rectal symptoms CDC LGV Guidelines.